Skip to main content
Monday, November 16, 2026Nov 16

Suit: US drug agency deemed firm ‘kingpin’ in ‘drug cartel’

FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Oklahoma's attorney general will announce a settlement Tuesday, March 26, 2019, with Purdue Pharma, one of the drug manufacturers named in a state lawsuit that accuses them of fueling the opioid epidemic. (AP Photo/Toby Talbot, File)
FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Oklahoma's attorney general will announce a settlement Tuesday, March 26, 2019, with Purdue Pharma, one of the drug manufacturers named in a state lawsuit that accuses them of fueling the opioid epidemic. (AP Photo/Toby Talbot, File)

NASHVILLE, Tenn. (AP) – The U.S. Drug Enforcement Administration viewed one drug-producing company as the “kingpin within a drug cartel,” according to a Tennessee lawsuit over the opioid epidemic.

A nearly 250-page amended complaint filed Monday in Circuit Court for Cumberland County said the DEA labeled Mallinckrodt a “kingpin” because it shipped opioids in high volumes to pharmacies it knew were feeding “pill mills” in Florida, which supplied Tennessee’s illegal drug market.

A spokesman for St. Louis-based Mallinckrodt called it a “gross and inflammatory mischaracterization of the facts designed to create headlines.”

The new claims come as drug companies field a flurry of lawsuits nationwide over the scourge of opioid abuse.

The Tennessee complaint was filed on behalf of five district attorneys general and a child born addicted to opioids.